Carsten Brockmeyer
Plus aucun poste en cours
Profil
Carsten Brockmeyer is the founder of Brockmeyer Biopharma GmbH, which was founded in 2010.
He was the Chief Executive Officer of Formycon AG.
He worked as a Science Director at Baxter International, Inc. from 1991 to 1998 and at Baxter Deutschland GmbH.
He was a Project Manager at Hexal AG and the Head-Project Management at Sandoz Pharmaceuticals AG.
He was also the General Manager at Hexal Biotech Forschungs GmbH.
Dr. Brockmeyer holds a doctorate degree from Hannover Medical School.
Anciens postes connus de Carsten Brockmeyer
| Sociétés | Poste | Fin |
|---|---|---|
| FORMYCON AG | Chief Executive Officer | 30/06/2022 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01/01/1998 |
| Hexal Biotech Forschungs GmbH | Corporate Officer/Principal | - |
Baxter Deutschland GmbH
 Baxter Deutschland GmbH Financial ConglomeratesFinance Part of Baxter International, Inc., Baxter Deutschland GmbH is a German company that changes the lives of millions of people around the world every day. The private company is based in Unterschleißheim, Germany. Baxter's products and therapies are used in hospitals and clinics, from the emergency room to the operating room, from the pharmacy to the intensive care unit, improving the care of patients at home. The company's focus on corporate governance is crucial in today's business environment, where investor and public confidence in the company is no longer based solely on financial performance or products and services. Baxter helps maximize safety, streamline procedures, and establish cost efficiencies throughout the clinic. The company was founded in 1960, and the CEO is Christian Wrabetz. | Corporate Officer/Principal | - |
| Brockmeyer Biopharma GmbH | Founder | - |
Formation de Carsten Brockmeyer
| Hannover Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BAXTER INTERNATIONAL INC. | Health Technology |
| FORMYCON AG | Health Technology |
| Entreprise privées | 5 |
|---|---|
Hexal AG
 Hexal AG Pharmaceuticals: MajorHealth Technology H e x a l AG develops, produces, markets and distributes modern generics and medicinal products. Its areas of emphasis are cardiovascular medicinal products, pain therapy medications and gastrointestinal products. The company was founded in April 1986 and is headquartered in Holzkirchen, Germany. | Health Technology |
Baxter Deutschland GmbH
Baxter Deutschland GmbH Financial ConglomeratesFinance Part of Baxter International, Inc., Baxter Deutschland GmbH is a German company that changes the lives of millions of people around the world every day. The private company is based in Unterschleißheim, Germany. Baxter's products and therapies are used in hospitals and clinics, from the emergency room to the operating room, from the pharmacy to the intensive care unit, improving the care of patients at home. The company's focus on corporate governance is crucial in today's business environment, where investor and public confidence in the company is no longer based solely on financial performance or products and services. Baxter helps maximize safety, streamline procedures, and establish cost efficiencies throughout the clinic. The company was founded in 1960, and the CEO is Christian Wrabetz. | Finance |
Sandoz Pharmaceuticals AG
 Sandoz Pharmaceuticals AG BiotechnologyHealth Technology Sandoz Pharmaceuticals AG develops and produces biopharmaceuticals. The firm specializes in the production of biopharmaceutical and biosimilars for the treatment and prevention of chronic diseases. It focuses on finding cure for diseases, such as cancer, multiple sclerosis, rheumatoid arthritis, and inherited metabolic disorders. The company was founded on January 6, 2006 and is headquartered in Rotkreuz, Switzerland. | Health Technology |
| Brockmeyer Biopharma GmbH | |
| Hexal Biotech Forschungs GmbH |
